Twenty Gradable Ranges, Twenty Delivered, and the Stock Went Nowhere: Initiating on Shell at Outperform

Results vs. Consensus

Q3 2025 Scorecard

Shell's headline earnings measure is Adjusted Earnings, a current-cost-of-supplies figure that strips identified items, and it is the number the market prints against. One point of housekeeping matters more than it should. Shell reports earnings per ordinary share; the US listing is an ADS equal to two ordinary shares. The quarter's $0.93 per ordinary share is $1.86 per ADS, and at least one wire treated the $0.93 as though it were the ADS figure and published a miss. On a consistent basis this was a beat of 8.1% on per-share earnings and 7.6% on the dollar total.

Year-Over-Year Comparison

The year-over-year column is the honest one and it is not flattering. Adjusted earnings are down 9.9%, adjusted EBITDA down 7.7%, operating cash flow down 16.9%, organic free cash flow down 22.3%, and ROACE has given back 340bp. The decline sits in Integrated Gas and Upstream, down 25.4% and 26.2%, and the nine-month picture is worse still: adjusted earnings of $15,273M against $20,055M, down 23.8%, on lower realised liquids and LNG prices, lower trading and optimisation margins, and lower chemicals and refining margins.

Two lines in that table do not follow the pattern, and they are the two that decide whether this is a business in decline or a business absorbing a down-cycle. Operating cash flow excluding working-capital movements is up 1.8% year-over-year, on earnings that are down 9.9%. And adjusted earnings per ADS are down only 3.1% against a dollar total down 9.9%, because the share count is 6.6% smaller. Per-share, the cycle has cost shareholders a third of what it cost the income statement.

Quarter-Over-Quarter Comparison

Assessment: Earnings

This is the cleanest quarter in Shell's recent set, and the reason is that the beat is broad rather than concentrated. Every operating segment improved sequentially. That is rare for an integrated major, where a good Integrated Gas quarter usually coincides with weak refining, or strong Marketing seasonality offsets a soft Upstream. The distribution of the improvement across five segments is what makes the operational story credible: it is consistent with an operating-performance programme working, and hard to reconcile with a single lucky trading book.

The counterweight is scale. Adjusted earnings of $5,432M are still 9.9% below a year ago and the nine-month total of $15,273M is 23.8% below the same period of 2024. ROACE at 9.4% sits below the 10%-plus Shell has set as its segment ambition, and it fell 340bp year-over-year. An investor buying this quarter is buying a business that is executing well inside a cycle that has moved against it, not a business that is growing.

Assessment: Cash and the Balance Sheet

Free cash flow of $9,950M against $5.7B of distributions is 1.74 times cover, and Shell funded its distribution entirely from cash generated and still reduced debt. That free cash flow includes $1,773M of divestment proceeds, among them the Colonial sale; organic free cash flow of $8,263M covered the distribution 1.45 times. Net debt fell $2,012M to $41,204M. The bridge the company gives is clean: $10.0B of free cash flow, less $3.6B of buybacks, $2.1B of dividends, $1.1B of lease additions and $0.8B of interest.

Two things deserve to be separated out. First, $28,571M of the $73,977M total debt is lease liabilities, so net debt excluding leases is $12,633M against $177,822M of equity. On that basis the balance sheet is close to unlevered, and the CFO's remark that "if you look at where our gearing has actually been, it's actually range between sort of 10% and 30% over time" is a fair description of where 18.8% sits. Second, gearing includes 40bp of increase from a non-cash remeasurement of the Dutch pension surplus, which was pre-flagged in the Q2 results and does not touch net debt. Absent it, gearing would have fallen 70bp rather than 30bp.

The item to carry forward is that the CFO volunteered the opposite outcome for next quarter. She said she expects net debt to rise in Q4 on "several billion" of recurring fourth-quarter items, naming German and US biofuels and emission certificate payments and the German mineral oil tax, plus higher capital expenditure and a seasonally weaker downstream. That is a specific, falsifiable statement and we will grade it.

Assessment: The Beat Against the Guide

On October 7, three weeks before the print, Shell published an update note containing twenty-four quantified ranges and four directional statements. Twenty of the ranges can be graded against the results and all twenty were met. The other four are segment underlying operating expenses, which Shell reconciles only at group level. All four directions delivered, although the size of one, Integrated Gas trading "significantly higher" than Q2, cannot be checked. For a company whose earnings are largely a function of prices it does not set, the ability to forecast its own controllables to that tolerance is the single most valuable thing in this release, and it is not in the headline number.

One item missed the pre-announcement. The Rotterdam HEFA biofuels cancellation was flagged on October 7 as approximately $0.6B of non-cash post-tax impairments and provisions in Marketing. The filing reports post-tax impairments of $579M and provisions of $186M, both mainly relating to that decision, within Marketing identified items of $988M pre-tax and $759M post-tax. Marketing's reported operating expense of $2,970M is also $170M above the top of the guided $2.4–2.8B underlying band, but that comparison cannot be graded, because Shell does not disclose underlying operating expense by segment. Neither changes the quarter, but a company that hit twenty of twenty should be marked on the miss as well.

Segment Performance

Integrated Gas

Adjusted earnings of $2,143M rose 23.4% sequentially on a 2% production increase to 934 kboe/d and an 8% liquefaction increase to 7.29Mt. LNG Canada is the swing factor: Train 1 delivered 13 cargoes in the quarter and Train 2 was described on the call as days away. The bridge Shell gives is a combined $208M increase from higher trading and optimisation contributions net of lower realised prices, plus $237M from higher volumes, less $108M of higher operating expenses.

LNG sales volumes of 18.88Mt outran liquefaction of 7.29Mt by a factor of 2.6, which is the shape of a portfolio that buys and resells third-party cargo as well as selling its own. Sales volumes are up 6% sequentially and 10.8% year-over-year even as liquefaction is down 2.8% year-over-year. That gap is the trading book, and it is why the segment's earnings are harder to model than its production.

"In Q3, we saw very strong as well, put its operational performance, not just on upstream, but also on our integrated gas business as well. And that gives us length and therefore, the ability to trade around those. In addition, of course, there were some arbs opening up in terms of the different price lines between both Asia and Europe as well, which give the results that you see, which we're really pleased with. It's not a given."
— Sinead Gorman, CFO

On the feed-gas side the CEO described a genuinely integrated operating model. AECO pricing went negative on a number of days in the quarter, and Shell responded by turning its own Groundbirch production down from roughly 100,000 boe/d of capacity to 70,000–75,000 boe/d and buying third-party gas instead.

Assessment: the operational story is unambiguous and the earnings story is not, because the same disclosure that shows volumes up 2% shows trading and price fused into a single $208M line. Integrated Gas is Shell's largest earnings segment and the one where we have the least visibility into how the money is made. Year-over-year the segment is still down 25.4%.

Upstream

Adjusted earnings of $1,804M rose 4.2% sequentially, which understates the operating result because it absorbs a $271M unfavourable movement from the rebalancing of participation interests in Brazil, a Tupi unitisation redetermination submitted to the Brazilian regulator. Strip that and the segment improved roughly $343M on $298M of higher volumes, $161M of favourable tax and $114M of lower well write-offs, against $241M of higher depreciation.

Production of 1,832 kboe/d is up 5.8% sequentially and 1.2% year-over-year, with liquids at 1,399 kb/d, up 5.9% year-over-year. The quarter's specifics are the most impressive operating disclosures in the release: Brazil at its highest ever quarterly production, the Gulf of America at its highest since 2005, and Whale reaching nameplate capacity in less than half the expected time with wells producing above the investment case.

"So this quarter, we still had turnarounds in both Brazil and in the Gulf, and those have gone to plan below schedule -- faster than scheduled plan as well as actually below budget. So really pleased with that. But also just the rigor in the way that the teams are following through on all the different operational metrics that we are focused on at the moment."
— Wael Sawan, CEO

Assessment: the best-run part of Shell, and the part where management's claims are most testable. Two deepwater basins at multi-year or all-time production highs, a project ramping in half the expected time, and turnarounds delivered under schedule and under budget. Year-over-year earnings are still down 26.2% because the price deck moved; the operating trajectory is the opposite direction and that divergence is the investment case in miniature.

Chemicals and Products

The segment swung from $118M to $550M, a $432M sequential gain and the largest single contributor to the quarter. The bridge is $706M of higher Products margins attributed "mainly" to trading and optimisation and higher refining margins, plus $96M of higher Chemicals margins, less $200M of unfavourable tax and $133M of higher operating expenses. Refinery utilisation rose to 96% from 94%, and chemicals plant utilisation to 80% from 72% on lower unplanned maintenance.

Underneath the aggregate is a split Shell discloses and which matters more than the total: Chemicals lost $207M and Products earned $758M. Chemicals sales volumes of 2,147kt are down 28.8% year-over-year. Shell's October 7 note had pre-flagged an indicative refining margin of $11.6/bbl against $8.9/bbl in Q2, and an indicative chemicals margin of $160/tonne against $166/tonne, so the direction of both sub-segments was known three weeks out.

"I would firstly just acknowledge once again the depth of the trough that we find ourselves in. And that's been just very challenging to navigate. We have already been working on a reduction of OpEx over a number of years, but it is just not enough. We were hoping that this is a typical cycle, and therefore, we would see the upside sooner than we are seeing it at the moment. We just don't see a line of sight to when that up cycle is going to come."
— Wael Sawan, CEO

Identified items include $710M of net gains on asset sales, mainly the Colonial Enterprises disposal completed in July, which the CFO sized on the call at around $1B of proceeds. Those gains sit outside adjusted earnings.

Assessment: the sequential improvement is real, and an unsized part of it is trading. The structural problem is untouched. Chemicals is loss-making, has no dated path to recovery by management's own admission, and carries $25B of the $45B of capital employed the CEO says is underperforming. The new commitment is "a few hundred million dollars more" of combined operating and capital cost removal over the coming months, with no benefit expected in Q4 and some expected in 2026. That is a cash-preservation plan, not a return to profitability.

Marketing

Adjusted earnings of $1,316M rose 9.8% sequentially and 11.3% year-over-year, on $270M of higher margins including seasonally stronger Mobility volumes and improved Sectors and Decarbonisation margins, partly offset by lower Lubricants margins and $145M of higher operating expenses. The CFO described it on the video as the segment's "second highest quarterly adjusted earnings in over a decade." Sales volumes of 2,824 kb/d are flat sequentially and down 4.1% year-over-year, so this is a unit-margin result rather than a volume result, achieved while divesting: roughly 400 lower-performing retail sites have been closed or sold year-to-date.

The segment also absorbed the quarter's largest charge. Identified items of $988M pre-tax ($759M post-tax) include post-tax impairments of $579M and provisions of $186M, both mainly relating to the decision not to restart the Rotterdam HEFA biofuels facility.

Assessment: the quietest good news in the release. Marketing is up 11.3% year-over-year on earnings, it is growing margin while shrinking its asset base, and it is the least price-exposed part of the portfolio. It is also the segment where reported operating expense of $2,970M sits $170M above the top of its guided $2.4–2.8B underlying range, a comparison that cannot be graded at segment level, and the CFO's explanation was higher advertising and marketing spend deliberately directed at premium products. On this quarter's evidence that spend is earning its return.

Renewables and Energy Solutions

Adjusted earnings of $92M against a $9M loss in Q2 and a $162M loss a year ago, on $131M of higher margins less $31M of higher operating expenses. Operating cash flow of $660M came primarily from $960M of working-capital inflows. Renewable generation capacity in operation is 3.8GW, and capacity under construction or committed for sale fell to 2.6GW from 3.8GW.

The filing is unusually direct about where the profit comes from: "Most Renewables and Energy Solutions activities were loss-making in the third quarter 2025, these were more than offset by positive Adjusted Earnings from trading and optimisation and energy marketing." A near-identical sentence, without "and energy marketing", appears for the nine-month period.

"What you can see us doing, of course, and what we talked about was moving from being 80% in producing assets or solar wind, different aspects like that, and 20% in trading and shifting that focus between now and sort of 2030 much more towards 20% into the producing assets and 80% into the trading side."
— Sinead Gorman, CFO

Assessment: the segment is being reshaped from an asset owner into a trading book, and the quarter's profit is an early sign it works. The portfolio actions are concrete: withdrawal from Atlantic Shores offshore wind, the sale of Inspire in the US, a 49% Cleantech stake in India, and the sell-down of five Savion solar projects. This is the $20B half of the underperforming-capital problem, and it is moving faster than the chemicals half.

Corporate

A net expense of $383M against $463M in Q2 and $643M a year ago, on favourable tax and currency movements partly offset by unfavourable net interest and higher operating expenses. The Q4 guide is a net expense of $600–800M, which would be the worst quarterly figure of the year and is worth $217–417M of sequential headwind on its own.

Assessment: Corporate carries all of Shell's finance expense, so a favourable quarter here is partly a tax-timing artefact. The Q4 guide is the clearest single quantification of how much worse management expects the next print to be.

Operating Metrics and Guidance Delivery

Shell publishes a quantified outlook three weeks before each print. Grading the Q3 result against the October 7 update note is the most direct available test of whether the operational improvement is repeatable or a good quarter, and it is the reason the rating is where it is.

Twenty-four quantified ranges guided, twenty gradable, and all twenty delivered inside the band. The other four are the segment underlying operating expense ranges, which cannot be graded because Shell reconciles underlying opex only at group level. Of the two point estimates, the HEFA charge came in above and the pension effect landed as flagged. All four directional statements delivered as well: Marketing adjusted earnings higher than Q2, Chemicals and Products trading and optimisation higher than Q2, a Chemicals sub-segment loss, and higher Integrated Gas trading and optimisation, although the "significantly higher" in that last one cannot be sized, because the filing reports it only net of lower realised prices.

The KPI table contains the quarter's central tension. Upstream liquids are up 5.9% year-over-year and group production is up 0.7%, while chemicals sales volumes are down 28.8% and refinery intake down 9.9%. Shell is growing the barrels and shrinking the molecules it converts. That is a deliberate portfolio choice and it is working on earnings mix, but it means the downstream asset base is running well below the scale it was built for.

Key Topics & Management Commentary

Overall Management Tone: confident and specific on operations, visibly less so on chemicals and on anything requiring a date. Management was direct about the negatives: the CEO put a credible 2026 oil oversupply on the record in answer to a question on demand, and the CFO pre-announced that net debt would rise next quarter. Where the answers thinned out was on quantification of the trading contribution, on whether chemicals remains core, and on the arbitration Shell had just lost, where the CEO said what he felt and then declined to continue.

1. Every Segment Improved, and Working Capital Did Not Flatter the Cash

All five operating segments improved sequentially and the Corporate loss narrowed. The sequential gain of $1,168M in adjusted earnings attributable to shareholders breaks down as Chemicals and Products $432M, Integrated Gas $406M, Marketing $117M, Renewables and Energy Solutions $101M, Upstream $72M and Corporate $80M, less $41M of higher non-controlling interest, with $1M of rounding.

The cash line is clean, though it did not rise with the earnings. Operating cash flow excluding working-capital movements was $12,235M against $12,323M in Q2 and $12,019M a year ago, flat while adjusted earnings rose 27.4%, with a working-capital swing of just $28M in the quarter. A quarter where headline operating cash flow rises because receivables unwound is a quarter to discount; this is not that quarter.

"This quarter, we delivered another strong set of results. Our adjusted earnings were $5.4 billion, and we generated $12.2 billion in cash flow from operations. The quarter-on-quarter improvement was driven by strong performance across our businesses with all demonstrating positive momentum."
— Sinead Gorman, CFO

Assessment: breadth is the signal. A single-segment beat on an integrated major is usually price or trading; a five-segment beat with flat working capital is operational. This is the evidence for the pillar we are establishing on execution.

2. Twenty Gradable Ranges, Twenty Delivered

Shell met every gradable range in its own October 7 update note. The closest call was chemicals utilisation at 80% against 79–83%, one point above the floor. Refinery utilisation at 96% sat at the midpoint of its 94–98% band. Nothing came in below.

The value of this is specific rather than sentimental. Shell's earnings are mostly a function of prices it does not set, so the only thing management can be held to is the controllables, and the controllables were forecast to inside a few percent three weeks ahead. Where an integrated major's guidance is usually a wide range restated loosely, this is a narrow range met precisely.

Assessment: one quarter does not make guidance credibility a thesis pillar, and we are explicit that it needs repeating. But it sets the bar for the next four prints and it is the specific thing we will grade each quarter.

3. LNG Canada Arrives, and Trading Goes Unsized Again

Train 1 delivered 13 cargoes in the quarter and Train 2 was described as days away with a first cargo imminent. Liquefaction rose 8% sequentially to 7.29Mt. But the earnings uplift is deferred: the CFO was explicit that having a train running is not the same as being able to trade around it.

"So you're right, that will be more into and the second half of next year. Pavilion very similar. We talked about it last quarter, if you remember, I talked about the fact that we're looking forward to getting those contracts in. We've got everything integrated into the portfolio at the moment, but actually how we manage them and utilize them, we need some of those to roll off and be able to have freedom on those volumes. And that will happen indeed towards the second half of 2026 as well."
— Sinead Gorman, CFO

Meanwhile the segment's disclosure still fuses trading with price. The Integrated Gas bridge attributes a combined $208M to "higher contributions from trading and optimisation and lower realised prices." The reader cannot separate them. The same pattern runs through Chemicals and Products, where a $706M Products margin improvement is attributed "mainly" to trading and optimisation without a figure, and through Renewables and Energy Solutions, where trading and optimisation and energy marketing are the only reason the segment is profitable at all.

Assessment: two unquantified things point in opposite directions. The LNG Canada and Pavilion earnings contribution is real and lands in H2 2026, which is a known, dated tailwind. The trading contribution is real and undated, and it is the reason the market will not pay a full multiple for these earnings. We treat the first as an asset and the second as a discount.

4. Chemicals Has No Line of Sight, and a New Cash-Preservation Plan

Chemicals lost $207M in the quarter on volumes down 28.8% year-over-year. The CEO's language was blunt: not a deep cycle to be waited out, but a trough with no visible end. His commitment is a few hundred million dollars more of combined operating and capital cost removal over the coming months, explicitly not landing in Q4 and hoped for in 2026, aimed at free cash flow neutrality rather than profitability.

Monaca has planned maintenance in Q4, and the CEO conceded there is "more work to do to really get ourselves to the point where we are running at full capacity in that asset."

Assessment: the honesty is welcome and the position is bad. Shell is now managing chemicals for cash preservation, which is the language a company uses about an asset it is preparing to exit or shrink. Asked directly whether chemicals should still be considered core, management described the cost plan and did not answer the question. That non-answer is the most informative thing in the section.

5. The $45B of Capital Employed That Is Not Earning

The CEO restated the Capital Markets Day 2025 figure without being asked to soften it: $45B of capital employed is underperforming, $25B in chemicals and $20B in Renewables and Energy Solutions. Against average capital employed of $221,322M, that is roughly 20% of the capital base the return-on-capital calculation divides by, and it is the arithmetic explanation for why ROACE is 9.4% rather than the 10%-plus Shell targets.

"We said in Capital Markets Day 2025 that we have $45 billion of capital employed that is underperforming for us. $25 billion of that is sitting in chemicals and $20 billion is sitting in res."
— Wael Sawan, CEO

The Renewables half is being addressed visibly: Atlantic Shores exited, Inspire sold, 49% of Cleantech India sold, five Savion solar projects sold down, and the stated shift from 80/20 assets-to-trading toward 20/80 by 2030. The chemicals half has a cost plan and no portfolio action.

Assessment: this is the clearest quantified upside in the story and the clearest quantified risk. Fixing $45B of capital employed earning nothing is worth several hundred basis points of ROACE; failing to fix it caps the multiple permanently. The Renewables side is moving and the chemicals side is not.

6. The Sixteenth Consecutive $3B-Plus Buyback

A $3.5B programme was announced for completion before the Q4 results, split evenly between London and Netherlands contracts, with authority for up to 500,000,000 ordinary shares, the entire remaining 2025 AGM authority. Shell completed the $3.5B announced at Q2 during the quarter and spent $3,610M on repurchases in the cash flow statement.

The compounding is the point. Shares in issue fell from 6,115,031,158 at the start of the year to 5,811,432,447 at September 30, a retirement of 303.6 million shares in nine months. The weighted average basic share count is down 6.6% year-over-year. On completion of the new programme, the CFO said, "we will have repurchased more than 1/4 of our shares over the last four years."

Four-quarter rolling shareholder distributions are 48% of operating cash flow, inside the 40–50% through-the-cycle target but at the upper end of it. The policy language was emphatic and repeated twice on the call.

"We keep coming back to the fact that on a distribution policy perspective, 40% to 50%, as you said, is sacrosanct. And we want to remain within that range and that's what we will do. And of course, then we look at how do we fund it, whether it's the free cash flow or whether we are looking to lean on the balance sheet, as we've said."
— Sinead Gorman, CFO

Assessment: a 6.6% annual reduction in share count is the single most reliable driver in this investment case and the one least dependent on the oil price. The caveat is in the policy itself. A payout ratio fixed at 40–50% of operating cash flow means the buyback shrinks when cash flow shrinks, and at 48% there is very little headroom left inside the band. If Q4 operating cash flow falls as guided, the arithmetic pressures the Q4 programme unless Shell leans on the balance sheet, which the CFO twice said it is willing to do.

7. Net Debt Falls $2.0B Without Leaning on the Balance Sheet

Net debt fell $2,012M to $41,204M and gearing 30bp to 18.8%, while $5.7B was distributed. Free cash flow of $9,950M covered the distribution 1.74 times. Excluding lease liabilities of $28,571M, net debt is $12,633M, down $1,628M sequentially.

The CFO was careful not to present this as a new normal. She used it to make the opposite point, that the balance sheet is a tool Shell is comfortable flexing in both directions, and then pre-announced that it would flex the other way next quarter.

"And actually, I would expect, of course, our gearing to our debt, net debt to go up next quarter, largely because what do I see? I see that sort of Q4 being one of those quarters where we always have some unusuals coming through... So those unusuals are quite a broad range, but they add up to several billion, whether it's the German and U.S. biofuels and certificates, the emission certificates payments that come through the German mineral oil tax, et cetera, but it adds up to a couple of billion, of course, next quarter."
— Sinead Gorman, CFO

Assessment: this quarter the distribution was self-funded and the debt still came down, which is the configuration that makes the 10.3% shareholder yield look sustainable rather than borrowed. Next quarter, by management's own account, it will not be. Whether the Q4 buyback holds at $3.5B through that is the first real test of the distribution policy.

8. Underlying Operating Expenses Jumped 10% Sequentially

Underlying operating expenses of $8,998M are up 10.5% sequentially from $8,145M, up 1.5% year-over-year, and down 3.7% for the nine months against the same period of 2024. The sequential jump was the only line item to draw sustained pushback in Q&A, and the CFO's answer was phasing: the full operating cost of LNG Canada and Monaca is now in the numbers while neither asset is yet at full output, and the cost of assets already sold has not yet come out.

"So what you're seeing is the likes of LNG Canada coming in with the full OpEx coming in, of course, because it's also just started up. So you have a lot of those ramp-up costs. You have the same, of course, when you're -- with respect to Chemicals and Monaca, all coming through whilst the platforms are still or the assets are still ramping up as well... You also have the same in terms of the divestments, there's also phasing around that."
— Sinead Gorman, CFO

On the $5–7B structural cost programme itself she was confident about the destination and non-committal about the path: "doing really well and continually driving the team towards that $5 billion to $7 billion target that we gave, which we have no doubt we will be into that range. It's just how fast and how hard we can go."

Assessment: the explanation is coherent and the nine-month figure supports it, but it is also unfalsifiable in a single quarter. Ramp-up costs preceding ramp-up revenue is exactly what you would expect from LNG Canada Train 1 and Monaca, and it is exactly what a company would say if costs were simply rising. The test is whether Q1 and Q2 2026 show the cost line falling as those assets reach full rates. No cumulative figure for the programme was given this quarter.

9. Rotterdam HEFA: A Charge Above the ~$600M Flagged

Shell decided in September not to restart construction of the Rotterdam HEFA biofuels facility, paused since 2024. The charge is $579M of impairments plus $186M of provisions, both post-tax and both mainly relating to the decision, $765M in all against the approximately $600M post-tax flagged on October 7. Marketing identified items in total were $988M pre-tax and $759M post-tax. It is the largest identified item in the quarter and it sits in Marketing.

The framing on the call put it as capital discipline rather than a write-off, and connected it to a broader point about policy risk in the investment committee's process.

"We took our time. It's a big decision to make and looked at it in every possible way and decided not at the moment to stop, right decision to be made. We continue to be very bullish about trading in biofuels in the prompt. But yes, the supply and demand fundamentals should play out further. We need to see how they play. And of course, we do need stable policy."
— Sinead Gorman, CFO

Assessment: killing a project that no longer clears the hurdle rate is the behaviour this thesis underwrites, and a charge of this size is a reasonable price for not spending the remaining capital. The uncomfortable read is that the charge exceeded a figure Shell itself published three weeks earlier, on an asset it had already been reassessing for a year.

10. The Q4 Guide Is Lower on Four of Seven Operating Lines

Shell guided Q4 refinery utilisation to 87–95% and chemicals utilisation to 71–79%. Both ranges sit entirely below the Q3 actuals of 96% and 80%. Corporate expense is guided to $600–800M against $383M delivered. Marketing sales volumes are guided to a 2,500–3,000 kb/d band whose midpoint is below the 2,824 kb/d just achieved. LNG liquefaction is guided up, to 7.4–8.0Mt from 7.29Mt, on the Train 2 start, and the Integrated Gas and Upstream production ranges have midpoints above Q3.

Cash capital expenditure is the largest swing. The full-year range of $20–22B was reaffirmed against $14,899M spent in nine months, which implies $5.1–7.1B in Q4 against $4,907M in Q3, a 4% to 45% sequential increase. Layer on the CFO's "several billion" of recurring Q4 payments and a weaker downstream, and the quarter is guided down on earnings, down on cash and up on debt.

Assessment: this is a management team guiding conservatively into a quarter it says will be seasonally poor, which is the pattern that produces beats. It is also a genuine step down, and the more important question is what it implies for the Q4 buyback given a payout ratio already at 48% of a shrinking cash flow.

11. The Arbitration Shell Lost and Would Not Size

Asked about the Venture Global arbitration, where a peer had secured a different outcome, the CEO's answer was unusually personal and then stopped.

"I think first, just to say deeply disappointed in the outcome of the arbitration tribunal, and we have a lot to reflect on and to learn, if I'm honest, in terms of how we can do -- to do better, because we deeply believe in our case, and we need to be able to continue to explore all pathways to protect our rights. And that is something, of course, we're looking at. So let me just leave it there out for now."
— Wael Sawan, CEO

No financial consequence was quantified, no amount at stake was disclosed, and no identified item in the quarter is attributed to it. The other two geopolitical exposures raised on the call were handled the same way: on Venezuela and Trinidad, and the OFAC-granted Dragon licence, the CEO said Shell is "on a wait and see mode at the moment"; on the UK North Sea, he declined to speculate ahead of the November budget while making clear that fiscal predictability determines whether Adura attracts capital.

Assessment: three unquantified legal, sanctions and fiscal exposures in one call, all answered with process rather than numbers. Individually each is defensible. Together they are the part of Shell's earnings that no amount of operational execution controls, and the reason we set conviction at 6 rather than higher.

Guidance & Outlook

This is a guide down, and management framed it as one rather than dressing it up. Four of the seven operating ranges point below the quarter just delivered, Corporate expense roughly doubles, capital expenditure rises, and the CFO volunteered that net debt will increase. The CEO added the macro overlay in answer to a question on demand.

"To your broader question around demand, what we see at the moment is indeed headwinds on the supply-demand fundamentals going into 2026 and a highly credible scenario that there is an oversupply in 2026... And so I think in the short to medium term, there are headwinds. Longer term, we continue to have strong conviction in crude prices going forward."
— Wael Sawan, CEO

Implied Q4 arithmetic: the seasonal items the CFO named add up to "a couple of billion" of cash outflow, capital expenditure rises by between $194M and $2,194M sequentially, Corporate expense worsens $217–417M, and both downstream utilisation bands sit below Q3. Against that, LNG liquefaction rises on the Train 2 start and the CFO expects continued strong operational performance. A Q4 adjusted-earnings figure in the $4.5–5.0B range is the reasonable read of what has been described, which would put FY2025 adjusted earnings around $19.8–20.3B against $23.7B in 2024 (the 2024 figure is derived: $20,055M reported for the first nine months of 2024, plus $3,660M for Q4 2024, which is the $18,933M trailing-four-quarter figure in the return-on-capital reference less the $15,273M reported for the first nine months of 2025).

Street at: consensus for the quarter just reported was $5.05B compiled by LSEG and $5.09B compiled by Vara for the company. Both were roughly 7% too low. This quarter's beat came against a conservatively-set bar, and the Q4 guide is set the same way.

Guidance style: narrow, quantified and met. Shell publishes ranges three weeks before the print that are tight enough to be falsified and then lands inside them. That is a different practice from the wide directional guidance typical of the peer group, and it deserves to be valued.

Analyst Q&A Highlights

Whether the Brazil and Gulf of America Performance Is Sustainable

The first question of the call went to the operating result rather than the earnings, and asked directly whether two basins at production records can hold that level into 2026 and beyond. Management separated the answer into the part that is structural and the part that is project timing, and committed to the structural half.

Q: "I thought the performance in the Upstream business across Brazil and the Gulf of America looked like it was a highlight of the third quarter. How sustainable do you see that performance going into 2026 and beyond."
— Matt Lofting, JPMorgan

A: "In terms of how much is this sort of sustainable? I believe that the improvements we have are very much sustainable. Of course, we will continue to want to bring those facilities down for maintenance on the annual basis that we typically do. But we've also seen some of the tailwinds that come from new projects. In Brazil, you have Mero-3 and Mero-4 that started up this year. And in a place like the Gulf, we've had Whale startup, actually start up and do much faster ramp-up than maybe traditionally we have seen in many of our deepwater projects."
— Wael Sawan, CEO

Assessment: a clean commitment, and the most useful sentence on the call for anyone modelling 2026 volumes. Note the caveat embedded in it, which is that annual turnarounds return and this quarter had them delivered early and under budget. The right read is that the base has stepped up and the quarterly path will still be lumpy.

How Much of the Integrated Gas Improvement Was the Asset and How Much Was the Market

The same questioner pressed on whether the Integrated Gas result reflected operational outperformance or a better trading environment, referencing management's own "new normal" framing from the prior quarter. The answer credited both and then, importantly, said the market half is already fading.

Q: "In the IG business, to what extent was the third quarter improvement in trading supported by operational outperformance versus greater market opportunity? In other words, is there any change to the new norm market conditions that we referenced in the summer?"
— Matt Lofting, JPMorgan

A: "In Q3, we saw very strong as well, put its operational performance, not just on upstream, but also on our integrated gas business as well. And that gives us length and therefore, the ability to trade around those. In addition, of course, there were some arbs opening up... When we then look at Q4 and beyond, what do we see in Q4? So already, we're seeing some of those opportunities, but nowhere near the amounts that we had before, and we don't see any one-off helps. Of course, as we look to 2026, what we're seeing at the moment, the spreads aren't there."
— Sinead Gorman, CFO

Assessment: the most valuable disclosure in the Q&A. Management confirms that part of the Integrated Gas beat came from arbitrage spreads between Asia and Europe, that those spreads are already narrower in Q4, and that as of the call they are not present for 2026. It is still not a number, but it is a direction and a timeline, and it says plainly that this quarter's trading contribution should not be annualised.

The 2026 Oversupply Call and What It Means for the Buyback

A question that paired the demand outlook with capital allocation drew the firmest statement of the call on distribution policy, and also the CEO's own bear case on 2026 crude. He put oversupply on the record and then argued the company is positioned for it.

Q: "What are you seeing demand-wise, because clearly, within the market that's competing seriously between is there an [indiscernible] versus market starting to tighten next year versus inventories not showing up? How do you see that given all the demand base you have? And how does the buyback fit into sort of that uncertainty?"
— Lydia Rainforth, Barclays

A: "I think in the context of the macro that we are going to be seeing what we have said, what we have already guided and continue to hold on to is our 40% to 50% distributions from CFFO is sacrosanct. And we very much intend to be able to continue to be within that range. And of course, we have positioned the company to be able to do that and to weather any potential downturns that emerge over the coming months a year or so."
— Wael Sawan, CEO

Assessment: read the answer carefully and it is a commitment to the ratio, not to the dollar amount. A payout of 40–50% of operating cash flow in a year when operating cash flow falls is a smaller buyback, and the four-quarter rolling figure is already at 48%. Management is telling investors the policy holds and declining to promise the absolute level. That is the correct answer and it is also the one that should temper anyone extrapolating $3.5B a quarter through a downturn.

Underlying Operating Expenses Up 10% in a Quarter

The sharpest line of questioning went at the cost line, framing a double-digit increase as noteworthy even allowing for inflation. The answer was entirely about phasing, and it pivoted to the nine-month figure.

Q: "I noticed that the line item, underlying OpEx was up sort of 10% year-on-year. And I was wondering what lies behind this. Of course, I know there's inflation in the system, there's inflation, almost everywhere, and it can be hard to fight. But 10% still struck me sort of as a reasonably noteworthy number."
— Martijn Rats, Morgan Stanley

A: "On the underlying OpEx, just a couple of things are really flowing through there. What you're seeing, of course, is a combination of, as you say, inflation, although we're doing really well to eat inflation, there's also new assets coming in as well. So a lot of that is about phasing... But costs are if you do it year-on-year, they're actually the 9-month costs are 4% dying at the end of the day."
— Sinead Gorman, CFO

Assessment: the 10% figure is the sequential change, not the year-over-year one, which is 1.5%; the nine-month figure is down 3.7%. Management did not correct the premise and answered the sequential jump on its merits, which was the right instinct because the sequential jump is the real observation. The answer is credible and unproven. LNG Canada and Monaca carrying full operating cost before full output is a genuine drag that should reverse; it is also indistinguishable in one quarter from costs simply going up.

Selling Colonial Pipeline When Trading Is the Growth Engine

A question with a sharp premise: if trading is increasingly central to Shell's earnings, infrastructure is precisely the asset class that gives traders optionality, so why sell a pipeline system. The answer was that the traders themselves brought the disposal.

Q: "Assets like that, I would imagine, are precisely the type of assets that really help the trading business. So there's probably some sort of trade-off there. And I was wondering how that type of consideration come into discussion about some of the disposals, particularly this one."
— Martijn Rats, Morgan Stanley

A: "From their perspective, they look at where are their touch points, where are their control points where they can maximize value. And for us, Colonial was not one of those. So it was just one that was in a long list of assets where they looked at it and said, I can put my capital elsewhere, that was really the rationale behind that... They brought the opportunity to us. We managed to execute it this quarter."
— Sinead Gorman, CFO

Assessment: the answer is more revealing about governance than about the pipeline. A trading organisation that volunteers the disposal of an asset it could have argued to keep is a trading organisation being held to a capital charge. That is the behaviour that makes a trading-weighted earnings stream more investable, and it is a partial mitigant to the disclosure complaint. Roughly $1B of proceeds and a $710M book gain, both outside adjusted earnings.

Whether Chemicals Is Still Core

The bluntest question of the call asked for a path back to profitability and whether the business belongs in Shell at all. Management answered the first half at length and did not address the second half.

Q: "I wonder what's the path back to profitability for the Chemicals business? And I'm wondering, is the Chemicals business -- should we consider it core for Shell going forward?"
— Doug Leggate, Wolfe Research

A: "We just don't see a line of sight to when that up cycle is going to come. And therefore, we have decided to really go after that cash preservation that I mentioned. The path towards free cash flow neutrality is squeezing more out of the OpEx juice and more out of CapEx. And that's where my previous reference to hundreds of millions more that we would look to be able to take out in the coming months to be able to at least get back to -- to stopping the bleeding from that unit."
— Wael Sawan, CEO

Assessment: the omission is the answer. A CEO who believed chemicals was strategically core would have said so in one sentence, because the question invited it. Instead the target was set at free cash flow neutrality and the verb was "stopping the bleeding." This is the single most important open question in the portfolio and the $25B of capital behind it is the reason ROACE is 9.4%.

LNG Canada Phase 2 and the Price of Political Risk

A two-part question on whether Phase 2 is advancing and how the investment committee prices policy risk after the biofuels cancellation. The Phase 2 answer was a timeline for a decision rather than a decision, and introduced a consideration that has not featured before: whether the global liquefaction build-out changes Shell's own calculus.

Q: "Just going back to LNG Canada. Have there been any further discussions on Phase 2 of the project? And I just wanted to update where we are there... The alternative for you is to just keep deploying more capital to the buyback which, obviously, the value proposition is fairly obvious. So just trying to understand how the investment committee is thinking about political risk across the various FIDs you have in the hopper?"
— Biraj Borkhataria, RBC

A: "The biggest things we're keeping an eye on at the moment is the joint venture is working with the various contractors to be able to at least frame a quality decision for us at some point next year... You're talking of the 70 million tonnes per annum of capacity that's been FID-ed. 60 million is sitting in the U.S. Now if we then think about future investment opportunities in liquefaction, it is about making sure that we are delivering to the demand destination from the right supply sources. Where Canada features is, of course, they have a transportation advantage vis-a-vis the U.S. it takes 10 days to ship from Canada to Asia versus 25% from the Gulf."
— Wael Sawan, CEO

Assessment: a Phase 2 decision has moved from an expectation to a framing exercise for "some point next year," and the reason given is not Canadian politics, where support was described as strong at both federal and provincial level, but the 70Mtpa of global capacity sanctioned this year. Shell is signalling it may not build Phase 2, and the alternative use of that capital is the buyback. For a shareholder underwriting per-share compounding, that is not a bad outcome.

The Scale of Inorganic Spend Needed to Hold Production Flat

A question on how much acquisition capital the production plan requires drew a refusal to give a number, a description of a high bar, and then an unprompted warning from the CFO about the Q4 balance sheet that was the most concrete forward statement of the call.

Q: "What do you think is the scale of inorganic investment that you'll need to continue this 1% hydrocarbon production growth well into the next decade? And if there's any area in your portfolio and particularly that you would like to deepen in scale?"
— Michele Della Vigna, Goldman Sachs

A: "I'm not going to give a particular scale of opportunity because at the end of the day, what we have said and what I've said in the past that we've maintained is we want to be value driven... We know that between now and 2030, the requirement to be able to sort of maintain liquids flat we've, by and large, we're almost there. So this is not about 2030 where we have high confidence. It's about building that funnel for the 2035-plus where we indicated in the Capital Markets Day chart that there was a gap of somewhere in the range of 350,000 barrels a day."
— Wael Sawan, CEO

Assessment: the substantive content is that the 2030 volume plan is essentially secured and the gap is a 2035-plus problem of roughly 350 kb/d. That removes near-term acquisition pressure, which is exactly what a shareholder wants heard alongside a CEO forecasting oversupply: Shell does not need to buy anything into a falling market. The CEO also disclosed that more proposals are crossing the desk at lower implied breakevens, "albeit none of them at an attractive enough level to be able to cross that high bar."

Why the Q4 Integrated Gas Framing Sounds More Conservative Than the Volumes

A questioner noted the mismatch between guiding liquefaction volumes up and sounding cautious on the segment, and asked what else is in the numbers. The answer added a detail not in the release: legacy trading positions are still expiring.

Q: "In an earlier question, at this time, you're sounding quite conservative. And yet I look liquefaction volumes should be up. Why would the ramp-up of those volumes not help you optimize margins in the fourth quarter? Are there other things in integrated gas we should be aware of? And can you just remind us where we are on the hedging impact there and the potential headwind there that was inside these numbers this quarter?"
— Josh Stone, UBS

A: "What I was mentioning earlier on was that we're seeing some of it at the moment, but less in Q4 than we did in Q3. So there is that sort of notice board. Those are closing at the moment... You also mentioned then the impact in terms of the runoff by the way, in terms of the losses of the legacy positions. So I think I've positioned probably back almost a year ago, but I said we'd run through 2025. We're still seeing those legacy positions expire over this year. That impact is less pronounced than it was at the start of the year... you will see that in Q4 as well."
— Sinead Gorman, CFO

Assessment: two separate Q4 drags on Integrated Gas, both confirmed and neither sized: narrowing arbitrage spreads and the tail of legacy hedge positions still rolling off. The useful part is that the legacy drag is described as diminishing and confined to 2025, which makes it a 2026 tailwind by elimination. Volumes up and margin capture down is a combination that argues against simply extrapolating the Q3 segment result.

What They're NOT Saying

1. No 2026 capital expenditure figure restated. The FY2025 range of $20–22B was reaffirmed, and the CFO referred to the $20–22B annual range that the 2025 Capital Markets Day set for 2025–2028, but FY2026 was not addressed on its own, in a call where the CEO forecast oversupply, flagged higher Q4 capital spending and described a growing acquisition funnel. For a company whose equity case rests on distributions being funded from free cash flow, whether 2026 holds inside that range is the most consequential number nobody asked about and nobody restated.
2. No cumulative figure for the $5–7B cost programme. The CFO expressed no doubt about landing in the range and gave no number for what has been booked to date, and no analyst pressed for one. A programme reported without a running total is a programme that cannot be graded.
3. The trading and optimisation contribution is never sized. Integrated Gas fuses trading with realised prices into a single $208M line. Chemicals and Products attributes a $706M improvement to trading "mainly." Renewables and Energy Solutions states that most activities were loss-making and trading and optimisation and energy marketing more than offset them, without saying by how much. Three of five segments describe their sequential movement in terms of a contribution the reader cannot measure.
4. No financial consequence disclosed for the Venture Global arbitration. The CEO expressed disappointment and declined to continue. No amount at stake, no provision, no identified item, no indication whether the outcome has any P&L effect at all.
5. Whether chemicals is core went unanswered. Asked in one clause, and the reply addressed only the cost plan. No update on the chemicals review set out at the 2025 Capital Markets Day, no exit structure, no disposal process, and no timeline to free cash flow neutrality beyond "the coming months."
6. No Q4 buyback indication. The new $3.5B programme runs to the Q4 results announcement, and management would not be drawn on the next one while simultaneously guiding cash flow down, net debt up and a payout ratio already at 48% of the 40–50% band.
7. The Brazil JV question was deflected to the JV. Asked about a portfolio company "crying out for fresh equity injections," the CFO said "it's a listed company, so I always look to the company to speak for itself." Shell's own exposure and any committed capital were not addressed.
8. No date for free cash flow neutrality in chemicals, and none for Monaca at full rates. The cost actions are sized as "a few hundred million dollars" and timed as "the coming months," explicitly excluded from Q4 and hoped for in 2026.
9. Namibia carries no capital figure. A decision on an appraisal well for a new horizon is expected "in the coming weeks" with no indication of scale, after appraisal results the CEO characterised as challenged by high gas-oil ratios and fluid mobility.
10. No quantification of the Trinidad and Venezuela exposure. The OFAC-granted Dragon licence was described as something Shell "still have to figure out," with staff welfare named as the first concern and no commercial consequence sized.

Market Reaction

• Pre-print setup: the shares closed at $75.55 on October 29, up 20.6% year-to-date against 17.2% for the S&P 500, up 15.2% over twelve months and 5.6% over the prior thirty days. That close sat $0.29 below the 52-week closing high of $75.84, inside a 52-week closing range of $59.75 to $75.84. Shell entered the print priced for good news.
• Reaction session: results were released at 07:00 GMT on October 30, before the US open. The shares opened at $75.59, traded a $74.66 to $76.38 range and closed at $74.73, down 1.1% or $0.82. The S&P 500 fell 1.0% the same session.
• Volume: 6.2 million shares against a 4.0 million thirty-day average, 1.5 times normal.
• Pre-market: the US line was quoted essentially flat, marginally above the prior close, before drifting lower with the broader tape through the session.

A 7.6% beat on the headline metric, a five-segment sequential improvement, a $2.0B reduction in net debt and a sixteenth consecutive $3B-plus buyback produced a move of one percentage point, in the same direction and of the same magnitude as the index. Stripping out the market, the print moved the stock by roughly a tenth of a percent. That is not a rejection of the quarter; it is the market saying it already knew.

The mechanism is visible in the setup. Shell went into the print near a 52-week high having outrun the index year-to-date, three weeks after publishing a guidance note whose twenty gradable ranges the quarter then met. The beat was against consensus, but the operational content had been pre-announced, and the price had absorbed it. The one element genuinely not in the October 7 note was the buyback size, and at $3.5B it matched the prior quarter rather than raising.

The more useful way to read the session is what it implies about the setup for the next one. A stock that does not fall on a guide-down of this specificity, and does not rise on a beat of this quality, is a stock trading on its distribution rather than on its quarterly earnings. That reduces the earnings sensitivity of the equity in both directions and puts the weight of the investment case on the durability of the payout.

Street Perspective

Debate: Is $5.4B a trough-quarter beat or the start of a re-rating?

Bull view: the bull case being made is that the numbers were solid across virtually every division, that the beat came with earnings growth and strong cash generation rather than from a single line, and that the Brazil and Gulf of America production records plus the LNG Canada ramp are structural additions rather than a favourable quarter. On this reading, adjusted earnings down 9.9% year-over-year understates the business because the price deck did the damage and the operating base improved underneath it.

Bear view: the bear camp contends that revenue fell to $68.2B from $71.1B with weakness across multiple divisions, that holding oil production broadly flat to 2030 leaves the equity a pure function of commodity prices, and that the stock has already re-rated: the prospective yield of roughly 4% compares with a ten-year average nearer 5.5%, which is valuation creep above the long-term average. The view circulating is that room for a near-term re-rating after this year's gains looks limited.

Our take: the bear case on valuation is the stronger half and the bear case on fundamentals is the weaker half. Shell has genuinely re-rated in yield terms and it is no longer cheap against its own history. But the fundamental complaint mostly reduces to disliking the oil price, and the two drivers we underwrite, the cost programme and the share count, do not need the oil price to work. The evidence for a re-rating is not this quarter's beat; it is twenty of twenty gradable ranges met, which is the kind of thing that changes a multiple slowly and never on the day.

Debate: Does a 10.3% shareholder yield compensate for a 9.4% ROACE?

Bull view: the argument is arithmetic. A 3.8% dividend plus a buyback retiring 6.4% of the market capitalisation a year returns more than a tenth of the equity value annually, funded 1.74 times over by free cash flow in the quarter just reported, while net debt fell. A shareholder does not need growth or a re-rating to earn a return; they need the payout to hold.

Bear view: the counter is that a 9.4% ROACE against a cost of capital in the same neighbourhood means Shell is distributing cash because it cannot reinvest it at an attractive return, and that $45B of capital employed earning nothing is the proof. A high shareholder yield on a business that cannot compound is a liquidation in instalments. And the payout ratio at 48% of a cash flow management has just guided lower means the buyback is the adjustment variable.

Our take: both are right and they resolve in the bull's favour at this price. The bear is correct that the yield is high partly because reinvestment options are poor, and the CEO's own $45B figure concedes it. But the response to a poor reinvestment opportunity set is to return the cash, and Shell is doing exactly that, while also shrinking the underperforming capital through disposals. The real vulnerability is the one the bear identifies second: the policy commits to a ratio, not a level. We will grade the Q4 programme against the $3.5B run-rate, and a print below $3.0B without a corresponding improvement elsewhere would change our view.

Debate: Should the trading contribution be discounted or capitalised?

Bull view: the case for capitalising it is that trading is a capability, not a windfall. The AECO episode, where Shell turned down its own Groundbirch production from roughly 100 kboe/d of capacity to 70–75 kboe/d and bought third-party gas because the economics were better, is an integrated system extracting value no standalone producer could. LNG sales volumes of 18.88Mt against 7.29Mt of liquefaction are the same point at scale. A trading organisation that volunteers the sale of a pipeline it does not need is being run to a capital charge.

Bear view: the case for discounting it is that it cannot be modelled. Three of five segments explain their sequential movement partly by trading and none of them size it. Shell's own CFO has said the Q3 arbitrage spreads are narrower in Q4 and absent for 2026 as things stand, and that legacy positions are still expiring. An earnings stream that is material, volatile, undisclosed and admitted to be fading is one a disciplined buyer marks down.

Our take: discount it, and say so explicitly rather than pretending to model it. This is the reason our multiple is 11x rather than 13x and the reason conviction is 6 rather than 8. The mitigating fact this quarter is that management volunteered the fade rather than letting investors discover it, which is more disclosure than the segment note contains. We are establishing this as a standing bear point and the specific thing that would retire it is a sized trading contribution, quarterly.

Model Update & Valuation Framework

Valuation

At the October 30 close of $74.73, with 5,811,432,447 ordinary shares in issue at September 30 and an ADS equal to two ordinary shares, the market capitalisation is roughly $217B. Trailing four-quarter adjusted earnings disclosed in the return-on-capital reference are $18,933M, which puts the equity at 11.5 times trailing earnings struck in the trough of both the chemicals and the refining cycle.

Our base case for 2026 is adjusted earnings of $21.5B on an average 2,760M ADS, which is $7.79 per ADS. At 11.0 times that gives $86, which is our twelve-month target and 15.1% above the current price. Adding the 3.8% dividend gives a total return of roughly 19%.

The multiple is the judgement, so it is worth being explicit about it. Eleven times is below the 11.5 times trailing, and deliberately so. Three things argue for a higher number: ROACE is depressed by $45B of capital employed that is being actively addressed on the Renewables side, the cost programme has $1.1B to $3.1B still to deliver against the $5–7B target on the $3.9B delivered through the first half, the last cumulative figure Shell gave, and twenty of twenty gradable ranges met is a governance property the peer group does not share. Three things argue for a lower number: a material and unsized trading contribution that management has said is fading, a chemicals business with no dated path to profitability, and the CEO's own credible 2026 oversupply scenario. We are not paying up for the first three until the trading disclosure improves, and we are not marking down for the second three while free cash flow covers the distribution 1.74 times.

Shareholder yield at the current price: the annualised dividend of $2.864 per ADS is a 3.8% yield, and the announced $3.5B quarterly programme annualises to $14.0B, or 6.4% of the market capitalisation. The combined 10.3% is funded from free cash flow of $9,950M in the quarter against $5.7B distributed. This is the number that carries the investment case, and the bear-case row above is what happens to it if the buyback is cut to the $3.0B floor.

Thesis Scorecard Post-Earnings

This is our initiation on Shell, so the pillars below are established here rather than carried forward. Each will be graded against subsequent quarters.

Overall: thesis established. Three drivers, two of which are independent of the commodity price, against three risks, two of which are disclosure and capital-allocation problems rather than operating ones. The quarter is evidence for the bull pillars and the guide is evidence for the bear ones.

Action: buy, with the Q4 buyback as the specific thing to grade. We are initiating at Outperform with an $86 twelve-month target. The downgrade trigger is explicit: a Q4 programme below $3.0B, or a 2026 capital expenditure guide materially above $22B, would move us to Hold, because either would convert the distribution from a funded policy into the adjustment variable.

Bottom Line

Shell beat a $5.05B consensus by 7.6%, improved every operating segment sequentially, landed inside all twenty gradable ranges it had published three weeks earlier, cut net debt by $2.0B while distributing $5.7B, and announced its sixteenth consecutive buyback of $3B or more. The stock fell 1.1% on a day the index fell 1.0%.

That non-reaction is the opportunity and the warning in one number. The warning is that the shares entered the print near a 52-week high with a prospective yield well below their ten-year average, so the operational good news was known and paid for. The opportunity is that the market is pricing the quarterly earnings, which are cyclical and partly opaque, rather than the two things that are neither: a cost programme with $1.1B to $3.1B still to come on the last disclosed total, and a share count falling 6.6% a year with free cash flow covering the distribution 1.74 times over.

The honest reservations are that return on capital is 9.4% with $45B of the balance sheet earning nothing, that a material share of this quarter's improvement is a trading contribution Shell declines to size and has already said is fading, and that management has guided the next quarter down on four of seven operating lines while forecasting a credible oil oversupply for 2026. None of those is a reason to avoid a 10.3% shareholder yield at 11.5 times trough-cycle earnings. All of them are reasons to hold conviction at 6 rather than higher, and to grade the Q4 buyback rather than assume it.

We are initiating on Shell at Outperform with a twelve-month target of $86.